- Home
- WNW vs KTTA Comparison
WNW vs KTTA Comparison
Compare WNW & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- KTTA
- Stock Information
- Founded
- WNW 2015
- KTTA 2020
- Country
- WNW China
- KTTA United States
- Employees
- WNW N/A
- KTTA N/A
- Industry
- WNW Catalog/Specialty Distribution
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- KTTA Health Care
- Exchange
- WNW Nasdaq
- KTTA Nasdaq
- Market Cap
- WNW 5.4M
- KTTA 5.5M
- IPO Year
- WNW 2020
- KTTA 2021
- Fundamental
- Price
- WNW N/A
- KTTA N/A
- Analyst Decision
- WNW
- KTTA
- Analyst Count
- WNW 0
- KTTA 0
- Target Price
- WNW N/A
- KTTA N/A
- AVG Volume (30 Days)
- WNW 47.6K
- KTTA 95.5K
- Earning Date
- WNW 11-14-2025
- KTTA 11-12-2025
- Dividend Yield
- WNW N/A
- KTTA N/A
- EPS Growth
- WNW N/A
- KTTA N/A
- EPS
- WNW 9.06
- KTTA N/A
- Revenue
- WNW $158,485.00
- KTTA N/A
- Revenue This Year
- WNW N/A
- KTTA N/A
- Revenue Next Year
- WNW N/A
- KTTA N/A
- P/E Ratio
- WNW $0.23
- KTTA N/A
- Revenue Growth
- WNW N/A
- KTTA N/A
- 52 Week Low
- WNW $0.95
- KTTA $0.65
- 52 Week High
- WNW $70.00
- KTTA $5.06
- Technical
- Relative Strength Index (RSI)
- WNW N/A
- KTTA N/A
- Support Level
- WNW N/A
- KTTA N/A
- Resistance Level
- WNW N/A
- KTTA N/A
- Average True Range (ATR)
- WNW 0.00
- KTTA 0.00
- MACD
- WNW 0.00
- KTTA 0.00
- Stochastic Oscillator
- WNW 0.00
- KTTA 0.00
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).